loading

Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
20.03%
85.39
71.14 83.34 84.07 81.80
Cost Of Revenue
20.27%
59.71
49.65 50.75 48.56 47.37
Gross Profit
19.49%
25.68
21.49 32.58 35.51 34.44
Operating Expenses
10.05%
61.75
56.11 68.82 50.86 54.15
Operating Income/Loss
4.19%
-36.07
-34.62 -36.24 -15.35 -19.71
Nonoperating Income/Loss
26.16%
6.383
8.644 6.964 7.841 -1.806
Income/Loss From Continuing Operations Before Tax
14.29%
-29.69
-25.98 -29.27 -7.509 -21.52
Income Tax Expense/Benefit, Deferred
91.96%
-0.09
-1.12 -0.104 -0.864 -0.113
Income Tax Expense/Benefit
104.12%
0.029
-0.704 -5.624 -0.683 -2.263
Net Income/Loss
17.59%
-29.72
-25.27 -23.65 -6.826 -19.26
Attributable To Noncontrolling Interest
57.81%
-0.189
-0.448 -0.232 -0.218 -0.299
Basic Average Shares
9.31%
28.00
30.88 0.069 30.75 30.54
Diluted Average Shares
9.31%
28.00
30.88 0.069 30.75 30.54
$6.1707
price up icon 2.50%
$20.21
price down icon 4.94%
XGN XGN
$7.5413
price up icon 0.95%
BNR BNR
$11.11
price down icon 0.36%
$2.966
price down icon 1.13%
$33.47
price up icon 0.51%
Capitalizzazione:     |  Volume (24 ore):